Found: 3
Select item for more details and to access through your institution.
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e164, doi. 10.1002/onco.13551
- By:
- Publication type:
- Article
State of the Science and Future Directions for Liquid Biopsies in Drug Development.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. 730, doi. 10.1634/theoncologist.2020-0246
- By:
- Publication type:
- Article
Primary Myeloid Sarcoma Masquerading as an Obstructing Duodenal Carcinoma.
- Published in:
- Case Reports in Hematology, 2012, p. 1, doi. 10.1155/2012/490438
- By:
- Publication type:
- Article